Provided by Tiger Trade Technology Pte. Ltd.

INVESCO PHARMACEUTICALS ETF

128.02
+0.53000.42%
Post-market: 128.020.00000.00%19:30 EDT
Volume:79.01K
Turnover:10.14M
Market Cap:532.56M
PE:6.64
High:129.29
Open:128.37
Low:127.73
Close:127.49
52wk High:131.68
52wk Low:90.01
Shares:4.16M
Float Shares:4.16M
Volume Ratio:4.20
T/O Rate:1.90%
Dividend:1.06
Dividend Rate:0.83%
EPS(TTM):19.29
EPS(LYR):21.73
ROE:23.89%
ROA:0.60%
PB:1.60
PE(LYR):5.89

Loading ...

More US Employers to Drop Weight-Loss Drugs in 2027, as Healthcare Costs Increase

Reuters
·
Aug 26

Lilly’s LY4395089 Interaction Study Marks Quiet but Important Early-Stage Progress

TIPRANKS
·
Aug 26

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Aug 25

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Political and General News Events from August 25

Reuters
·
Aug 25

China's Shandong Xinhua Profit Drops on Domestic, International Competition

Reuters
·
Aug 25

China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales

Reuters
·
Aug 25

Austar Lifesciences H1 Profit Drops on Higher R&D Spending

Reuters
·
Aug 25

WuXi Biologics H1 Net Profit up on Margin Expansion

Reuters
·
Aug 25

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Aug 25

Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board

Reuters
·
Aug 25

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 25

Molecular Partners H1 Net Loss Narrows on Lower R&D Expenses

Reuters
·
Aug 25

US FDA Expands Approval for J&J's Drug for Rare Blood Disorder

Reuters
·
Aug 25

FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment

Reuters
·
Aug 25

FDA Approves Imaavy® as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia (Waiha), Representing a Landmark Advancement for Patients

THOMSON REUTERS
·
Aug 25

Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 25

Oruka Therapeutics Names Todd Edwards Chief Commercial Officer

Reuters
·
Aug 25

Eli Lilly Stock (LLY) in Focus as Hedge Fund Titan Ken Griffin Quadruples Position

TIPRANKS
·
Aug 25

Sector Update: Healthcare

MT Newswires Live
·
Aug 25